Ravishankar
Deepak Ravishankar, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20150149892 | SYSTEM AND METHOD FOR AUTOMATICALLY GENERATING KEYWORDS - An information handling system is disclosed for generating tags of a file including a document or a webpage posting. The generating tags of a file include converting a webpage posting to a PDF document. The method further includes extracting tags provided by users. The method includes scanning the extracted data from a glossary PDF document to identify keywords of the glossary PDF document in accordance with a sentence length. The method further includes extracting data from the PDF document and scanning the extracted data to identify keywords of the PDF document in accordance with a sentence length. The method further includes reapplying selected keywords to the tags of the file. | 05-28-2015 |
Hariharan Ravishankar, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20150157275 | RESPIRATORY STRESS DETECTION - Embodiments of the disclosure are directed to a system for analysis of respiratory distress in hospitalized patients. The system performs multi-parametric simultaneous analysis of respiration rate (RR) and pulse oximetry (SpO | 06-11-2015 |
Hema Ravishankar, Nassim Ville SG
Patent application number | Description | Published |
---|---|---|
20130142877 | PHARMACEUTICAL DOSAGE FORM COMPRISING ONE OR MORE ANTIRETROVIRAL ACTIVE INGREDIENTS - The invention relates to a pharmaceutical dosage form comprising one or more antiretroviral active ingredients in the form of a solid dispersion or solid solution in a matrix, wherein said matrix comprises an amino(meth)acrylate copolymer, characterized in that the matrix does not contain any essential amounts of pharmaceutically acceptable surfactants with an HLB value from 12 to 18 and in that the matrix comprises a mono carboxylic acid or an alcohol with 12 to 22 carbon atoms or both. | 06-06-2013 |
Hema Ravishankar, Chembur IN
Patent application number | Description | Published |
---|---|---|
20080220080 | Multiparticulate Pharmaceutical form Comprising Pellets with a Substance Having a Modular Effect in Relation to Active Ingredient Release - The invention relates to a multiparticulate pharmaceutical form, comprising pellets with a multilayer structure for controlled active ingredient release, comprising a) a core layer comprising a substance having a modulating effect, b) an inner controlling layer which influences the delivery of the substance having a modulating effect, consisting of pharmaceutically usable polymers, waxes, resins and/or proteins, c) an active ingredient layer comprising an active pharmaceutical ingredient and, where appropriate, a substance having a modulating effect, d) an outer controlling layer comprising at least 60% by weight of one or a mixture of a plurality of (meth)acrylate copolymers where the layers may additionally and in a manner known per se comprise pharmaceutically usual excipients, where the outer controlling layer d) has a thickness from 20 to less than 55 μm and contains 0.1 to 10% by weight of glycerol monostearate, where the multiparticulate pharmaceutical form contains 20 to 60% by weight of the pellets, which are compressed in mixture with 80 to 40% by weight of an outer phase which consists from 50 to 100% by weight of a cellulose or a derivate of cellulose and optionally 0 to 50% by weight of further pharmaceutical excipients. | 09-11-2008 |
20100247639 | COATED PHARMACEUTICAL OR NUTRACEUTICAL PREPARATION WITH ENHANCED ACTIVE SUBSTANCE RELEASE IN THE COLON - The present invention relates to a pharmaceutical or nutraceutical preparation comprising a) a core containing a pharmaceutically or nutraceutically active substance; and b) an inner controlling layer surrounding the core comprising i) one or a mixture of a plurality of (meth)acrylate copolymers bearing a cationic group or a group that can be converted to a cationic group; and ii) one or a mixture of a plurality of polymers or copolymers bearing an anionic group or group that can be converted to an anionic group; and c) an outer controlling layer comprising one or a mixture of a plurality of polymers or copolymers bearing an anionic group or group that can be converted to an anionic group and to tablets or capsules comprising same. | 09-30-2010 |
20100255092 | COATED PHARMACEUTICAL OR NUTRACEUTICAL PREPARATION WITH ACCELERATED CONTROLLED ACTIVE SUBSTANCE RELEASE - The present invention relates to pharmaceutical or nutraceutical preparations comprising a) a core containing a pharmaceutically or nutraceutically active substance; and b) a controlling layer surrounding the core comprising i) 55 to 92% by weight based on the total weight of (meth)acrylic copolymers present in the layer of one or a mixture of a plurality of (meth)acrylate copolymers composed of 80 to 98% by weight based on the weight of the (meth)acrylic copolymer of structural units derived from Ci to C4 alkyl esters of (meth)acrylic acid and 2 to 20% by weight based on the weight of the (meth)acrylic copolymer of structural units derived from (meth)acrylate monomers with a quaternary ammonium group in the alkyl radical; and ii) 8 to 45% by weight based on the total weight of (meth)acrylic copolymers present in the layer of one or a mixture of a plurality of (meth)acrylate copolymers composed of more than 5 to 59% by weight based on the weight of the copolymer of structural units derived from acrylic acid or methacrylic acid, and to tablets and capsules containing same. | 10-07-2010 |
20100291202 | COATED PHARMACEUTICAL OR NUTRACEUTICAL PREPARATION WITH ENHANCED PULSED ACTIVE SUBSTANCE RELEASE - The present invention relates to a pharmaceutical or nutraceutical preparation comprising a) a core containing a pharmaceutically or nutraceutically active substance and a substance that acts in a modulatory manner with regard of the release of pharmaceutically or nutraceutically active substances; and b) a controlling layer surrounding the core comprising i) 55 to 92% by weight based on the total weight of (meth)acrylic copolymers present in the layer of one or a mixture of a plurality of (meth)acrylate copolymers composed of 80 to 98% by weight based on the weight of the (meth)acrylic copolymer of structural units derived from C | 11-18-2010 |
20110070302 | COATED PHARMACEUTICAL OR NUTRACEUTICAL PREPARATION WITH ACCELERATED CONTROLLED ACTIVE SUBSTANCE RELEASE - The present invention relates to pharmaceutical or nutraceutical preparations comprising a) a core containing a pharmaceutically or nutraceutically active substance; and b) a controlling layer surrounding the core comprising | 03-24-2011 |
Raman Ravishankar, Singapore SG
Patent application number | Description | Published |
---|---|---|
20080305036 | Crystalline Oxide Material And Its Synthesis - Zeolites may be natural or synthetic and are inorganic crystalline aluminosilicates, with a highly regular structure of pores and channels rendering them suitable for molecular sieving, adsorption, ion exchange, dehydration, and rehydration processes for example. They generally have a definite crystalline structure as evidenced by x-ray diffraction. The present invention relates to the area of zeolites and its method of production. More particularly but not exclusively it relates to a novel zeolite ICS-3 in its “as synthesized” and its calcined forms and the method of producing both these forms. | 12-11-2008 |
Raman Ravishankar, Bengaluru IN
Patent application number | Description | Published |
---|---|---|
20150273448 | CATALYST COMPOSITE FOR THE REDUCTION OF OLEFINS IN THE FCC NAPHTHA STREAM - The present disclosure relates to a catalyst composition comprising (a) at least one rare earth metal, (b) at least one zeolite, and (c) at least one diluent, wherein, said rare earth metal is impregnated in at least one of (b) and (c); the ratio of said zeolite to said diluent ranges from 1:9 to 9:1; and the amount of said rare earth metal is in the range of 0.1 to 20 w/w %. The present disclosure also relates to a process for preparing a catalyst composition. Further, the present disclosure relates to a process for reducing the olefin content in a hydrocarbon stream using the catalyst of the present disclosure. | 10-01-2015 |
20150273451 | ZEOLITE BASED CATALYST COMPOSITION FOR THE REDUCTION OF OLEFINS IN FCC NAPHTHA - The present disclosure relates to a zeolite based catalyst composition comprising i. at least one rare earth metal, ii. at least one zeolite, and iii. optionally, at least one promoter; wherein, said rare earth metal is impregnated in said zeolite. The amount of said rare earth metal in said composition is in the range of 0.1 to 20 w/w %. The present disclosure also relates to a process for preparing a catalyst composition. Further, the present disclosure relates to a process for reducing olefin content in a hydrocarbon stream using the catalyst of the present disclosure. | 10-01-2015 |
Satish Kumar Ravishankar, Chennai IN
Patent application number | Description | Published |
---|---|---|
20120236716 | PROFILE-BASED QUALITY OF SERVICE FOR WIRELESS COMMUNICATION SYSTEMS - A profile-based quality of service (QoS) priority assignment mechanism can be implemented in a wireless communication network. In one embodiment, a plurality of network identifiers (e.g., SSIDs) associated with a plurality of client network devices that are communicatively coupled with an access point of the wireless communication network are determined. It is further determined which QoS profile of a plurality of QoS profiles supported by the access point is associated with each network identifier associated with each of the plurality of client network devices. A plurality of pending communications associated with the plurality of network devices are detected. A QoS transmission priority level is assigned to each of the pending communications associated with the plurality of network devices based, at least in part, on the QoS profile associated with each pending communication. A transmission of data associated with one of the plurality of pending communications is initiated based, at least in part, on the QoS transmission priority level assigned to each pending communication. | 09-20-2012 |